Ginsenoside Rg1 inhibits the mTOR/NF-κB pathway in podocytes under HG conditions, blocks the activation of NLRP3 to not cause pyroptosis, and improves the renal function of DKD mice (Wang et al. 2020). Here, NLRP3 is linked to diabetic kidney disease.